SEARCH

SEARCH BY CITATION

References

  • Borthakur, A., Bhattacharyya, S., Alrefai, W.A., Tobacman, J.K., Ramaswamy, K., and Dudeja, P.K. (2010) Platelet-activating factor-induced NF-κB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflamm Bowel Dis 16: 593603.
  • Dan, H., Cooper, M.J., Cogswell, P.C., Duncan, J.A., Ting, J.P., and Baldwin, A.S. (2014) Akt-dependent regulation of NF-kB is controlled by mTOR and Raptor in association with IKK. Genes Dev 22: 14901500.
  • Diaz, M.H., and Hauser, A.R. (2010) Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia. Infect Immun 78: 14471456.
  • Diaz, M.H., Shaver, C.M., King, J.D., Musunuri, S., Kazzaz, J.A., and Hauser, A.R. (2008) Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun 76: 44144421.
  • El-Solh, A.A., Hattemer, A., Hauser, A.R., Alhajhusain, A., and Vora, H. (2012) Clinical outcomes of type III Pseudomonas aeruginosa bacteremia. Crit Care Med 40: 11571163.
  • Finck-Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener-Kronish, J.P., Fleiszig, S.M., et al. (1997) ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25: 547557.
  • Fujitani, S., Sun, H.Y., Yu, V.L., and Weingarten, J.A. (2011) Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest 139: 909919.
  • Garcia, C.C., Russo, R.C., Guabiraba, R., Fagundes, C.T., Polidoro, R.B., Tavares, L.P., et al. (2010) Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog 6: e1001171.
  • He, J., Baldini, R.L., Déziel, E., Saucier, M., Zhang, Q., Liberati, N.T., et al. (2004) The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc Natl Acad Sci USA 101: 25302535.
  • Howell, H.A., Logan, L.K., and Hauser, A.R. (2013) Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia. mBio 4: e0003213.
  • Hussain, A.R., Ahmed, S.O., Ahmed, M., Khan, O.S., AbdulMohsen, S.A., Platanias, L.C., et al. (2012) Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis. PLoS ONE 7: e39945.
  • Kravchenko, V.V., Pan, Z., Han, J., Herbert, J.M., Ulevitch, R.J., and Ye, R.D. (1995) Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J Biol Chem 270: 1492814934.
  • Kung, V.L., Ozer, E.A., and Hauser, A.R. (2010) The accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol Rev 74: 621641.
  • Lacerda-Queiroz, N., Rachid, M.A., Teixeira, M.M., and Teixeira, A.L. (2013) The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria. Int J Parasitol 43: 1115.
  • de Lima, C.D.M., Calegari-Silva, T.C., Pereira, R.M., Santos, S.A., Lopes, U.G., Plotkowski, M.C., and Saliba, A.M. (2012) ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection. PLoS ONE 7: e41772.
  • Machado, G.B., de Assis, M.C., Leão, R., Saliba, A.M., Silva, M.C., Suassuna, J.H., et al. (2010) ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis. Shock 33: 315321.
  • Machado, G.B., Oliveira, A.V., Saliba, A.M., Lima, C.D.M., Suassuna, J.H.R., and Plotkowski, M.C. (2011) Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. Respir Res 12: 104.
  • Moreno, S.E., Alves-Filho, J.C., Rios-Santos, F., Silva, J.S., Ferreira, S.H., Cunha, F.Q., and Teixeira, M.M. (2006) Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. J Immunol 177: 12641271.
  • Mutoh, H., Bito, H., Minami, M., Nakamura, M., Honda, Z., Izumi, T., et al. (1993) Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor. FEBS Lett 22: 129134.
  • Mutoh, H., Ishii, S., Izumi, T., Kato, S., and Shimizu, T. (1994) Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B. Biochem Biophys Res Commun 205: 11371142.
  • Park, A.-S., Na, H.-K., Kim, E.-H., Cha, Y.N., and Surh, Y.J. (2009) 4-Hydroxyestradiol Induces Anchorage-Independent Growth of Human Mammary Epithelial Cells via Activation of I kB Kinase: potential Role of Reactive Oxygen Species. Cancer Res 69: 24162424.
  • Park, O.J., Han, J.Y., Baik, J.E., Jeon, J.H., Kang, S.S., Yun, C.H., et al. (2013) Lipoteichoic acid of Enterococcus faecalis induces the expression of chemokines via TLR2 and PAFR signaling pathways. J Leukoc Biol 94: 12751284.
  • Plotkowski, M.C., Plotkowski, M.C., Feliciano, L.F., Machado, G.B., Cunha, L.G., Jr, Freitas, C., et al. (2008) ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells. Eur Respir J 32: 15911598.
  • Rabin, S.D., Veesenmeyer, J.L., Bieging, K.T., and Hauser, A.R. (2006) A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells. Infect Immun 74: 25522561.
  • Rabin, S.D.P., and Hauser, A.R. (2005) Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun 73: 573582.
  • Roy-Burman, A., Savel, R.H., Racine, S., Swanson, B.L., Revadigar, N.S., Fujimoto, J., et al. (2001) Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 183: 17671774.
  • Saliba, A.M., Nascimento, D.O., Silva, M.C.A., Assis, M.C., Gayer, C.R.M., Raymond, B., et al. (2005) Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell Microbiol 7: 18111822.
  • Saliba, A.M., Assis, M.C., Nishi, R., Raymond, B., Marques Ede, A., Lopes, U.G., et al. (2006) Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU. Microbes Infect 8: 450459.
  • Sato, H., Frank, D.W., Hillard, C.J., Feix, J.B., Pankhaniya, R.R., Pankhaniya, R.R., et al. (2003) The mechanism of action of the Pseudomonas aeruginosa encoded type III cytotoxin, ExoU. EMBO J 22: 29592969.
  • Shaver, C.M., and Hauser, A.R. (2004) Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 72: 69696977.
  • Sitkiewicz, I., Stockbauer, K.E., and Musser, J.M. (2007) Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis. Trends Microbiol 15: 6369.
  • Stafforini, D.M., McIntyre, T.M., Zimmerman, G.A., and Prescott, S.M. (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40: 643672.
  • Venkatesha, R.T., Ahamed, J., Nuesch, C., Zaidi, A.K., and Ali, H. (2004) Platelet-activating factor-induced chemokine gene expression requires NF-kappaB activation and Ca2+/.calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment. J Biol Chem 279: 4460644612.
  • Wareham, D.W., and Curtis, M.A. (2007) A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates. Int J Med Microbiol 297: 227234.